Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells (vol 112, pg 1895, 2015)

2025-03-14

0

PRE

AI

DOI：10.1038/s41416-025-02973-y

Original

Original request for help

Share

Save